Tag: pharmaceuticals

The global health and wellness market has entered a period of rapid and sustained expansion, driven by innovation across pharmaceuticals, wellness, and digital health. Health...

Compliance risk intelligence in the health and life sciences sector is becoming more prominent as the market grows. The industry — spanning biotechnology, pharmaceuticals,...

Innovation and regulation have always shared a complex relationship, and few stories illustrate this better than the discovery and mass production of penicillin. While innovation...

Adverse media screening, traditionally a staple in the banking sector for anti-money laundering (AML), fraud prevention, and regulatory compliance, has now become a critical tool across various industries. As businesses navigate a world riddled with supply chain disruptions, geopolitical instability, and cyber threats, the importance of real-time risk intelligence cannot be overstated.